StemBioSys Announces European Distribution Agreement with Cellaviva AB of Sweden
SAN ANTONIO – StemBioSys Inc. announced today that it has entered into an agreement with
Cellaviva AB to distribute and market StemBioSys products. Cellaviva will be the exclusive
distributor for StemBioSys in Sweden and Denmark. The agreement also grants nonexclusive
rights to Cellaviva for the remainder of Europe.
Initially, the agreement will cover StemBioSys’ cell expansion product BM-HPME®, but
as additional products are added to StemBioSys’ portfolio in the future, these products likely will
also be included in the distribution agreement, according to StemBioSys President & CEO Bob
Hutchens.
“Europe is one of the leading areas in stem cell research and we are delighted to have
the opportunity to gain direct access to this market though our partnership with Cellaviva,”
Hutchens said. “In Sweden and Denmark, Cellaviva has a unique leading position in stem cell
research, and we are very pleased to announce them as our e

